Stay up to date

Latest News

30th November 2025

Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease

Mitochondrial Disease https://www.nejm.org/doi/full/10.1056/NEJMoa2503658 Mitochondrial DNA (mtDNA) diseases are inherited conditions passed from mother to child that can cause severe, sometimes fatal health problems. These diseases occur when the mitochondria do not work properly due to faulty DNA. There are currently very few treatment options, and women with mtDNA mutations face uncertainty about passing the condition […]

30th November 2025

Dysfunctional LHX6 pallido-subthalamic projections mediate epileptic events in a mouse model of Leigh Syndrome

Leigh Syndrome https://www.jci.org/articles/view/187571 Leigh Syndrome (LS) is a rare neurological disorder caused by defects in mitochondria, the cell’s energy supplier. Many individuals with LS experience treatment-resistant seizures, but the mechanisms behind this mitochondrial epilepsy remain poorly understood. In this study, researchers used a mouse model lacking a key mitochondrial protein, NDUFS4, which closely mimics human […]

30th November 2025

Clinical and genetic analysis of ERCC8-Related cockayne syndrome: hepatic dysfunction as a biomarker, anhidrosis as a rare feature, and rehabilitation outcomes for ankle contractures

Cockayne Syndrome https://pmc.ncbi.nlm.nih.gov/articles/PMC12364674 Cockayne Syndrome (CS) is a rare inherited disorder that progressively affects growth and multiple organs, including the brain. CS is often misdiagnosed as clinical manifestations overlap with cerebral palsy (CP). This study, conducted in China, analysed the cases of eight children (6 males, 2 females) with ERCC8 gene-related CS, who were initially […]

30th November 2025

Growth Differentiation Factor 15 Elevation in the Central Nervous System Is Associated With Failure to Thrive in Alexander Disease

Alexander disease (AxD) https://onlinelibrary.wiley.com/doi/10.1002/acn3.70209 Alexander Disease (AxD) is a rare, genetic neurological disorder caused by mutations in the GFAP gene. It primarily affects astrocytes and leads to symptoms such as developmental delays, seizures, and a severe problem known as failure to thrive, where affected children struggle to gain weight and maintain muscle and fat. This […]

30th November 2025

Case Report: Heterozygous ADAR c.3019G>A pathogenic variant associated with variable neurological symptoms and incomplete penetrance in a four-generational family

Aicardi-Goutières syndrome (AGS) https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1453496/full This study explored a four-generation family carrying a specific change in the ADAR gene (c.3019G>A) to understand how it affects the immune system and the brain. The ADAR gene normally helps regulate the body’s immune response by editing RNA, and when it doesn’t function properly, the immune system may become overactive […]

30th November 2025

Hypogonadism in adult males with adrenoleukodystrophy

Adrenoleukodystrophy (ALD) https://www.sciencedirect.com/science/article/pii/S0003426625007838 This study examines how the rare genetic disorder X‑linked adrenoleukodystrophy (ALD) may affect male hormone production, specifically the function of the testes and hormonal control of male characteristics, known as hypogonadism. ALD is caused by mutations in the gene ABCD1, which disrupts the body’s ability to break down very-long-chain fatty acids (VLCFAs). […]

30th November 2025

Clinical and radiological characteristics of adult-onset X-linked adrenoleukodystrophy: a Chinese cohort study and review of the literature

Adrenoleukodystrophy (ALD) https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-025-04449-1 Adult-onset X-linked adrenoleukodystrophy (ALD) is a rare inherited condition that affects the brain, spinal cord and adrenal glands. In ALD, the body cannot properly break down very long-chain fatty acids (VLCFAs), which then build up and damage the nervous system. In this article, researchers studied seven Chinese men diagnosed with adult-onset ALD […]

30th November 2025

Kyowa Kirin and Orchard Therapeutics Announce OTL-200 Granted Orphan Regenerative Medicine Product Designation for Early-onset MLD in Japan

Metachromatic Leukodystrophy (MLD) https://ir.orchard-tx.com/news-releases/news-release-details/kyowa-kirin-and-orchard-therapeutics-announce-otl-200-granted Kyowa Kirin and Orchard Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) has granted Orphan Regenerative Medicine Product Designation to OTL-200, a gene therapy for the treatment of pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile (PSEJ), and early-symptomatic early juvenile (ESEJ) which are collectively referred to as early-onset […]

30th November 2025

ImmuneSensor Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations from the U.S. FDA for cGAS Inhibitor Drug Candidate, IMSB301, for the Treatment of Aicardi Goutières Syndrome (AGS)

Aicardi-Goutières syndrome (AGS) https://www.immunesensor.com/news/112024 The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) for ImmuneSensor Therapeutics drug candidate IMSB301 for Aicardi Goutières Syndrome (AGS) which is currently in an ongoing Phase 1 trial. ODD was introduced to encourage the development of drugs to treat conditions […]

27th November 2025

Research Summary: November 2025

Research summary of recent leukodystrophy research and clinical trials, includes article summaries and direct links to websites and articles. To access the summary: Research Summary – November 2025 Please be aware these summaries are produced voluntarily by Biomedical Science students and are their interpretations of the information and findings. This information is reviewed by our […]